Non-Crosslinked Hyaluronic Acid Redensity 1® Supports Cell Viability, Proliferation, and Collagen Deposition in Early Burn Management
Open Access
- 23 December 2025
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (1) , 21
Abstract
Background/Objectives: Burn injuries pose a significant challenge due to tissue damage and impaired healing. Cell-based therapies offer promise by delivering therapeutic cells to the wound site. However, effective cell delivery remains a critical hurdle. This study investigates the potential of non-crosslinked hyaluronic acid (HA) as a simple, versatile carrier for delivering autologous keratinocytes and fibroblasts to treat early burn wounds. Methods: Primary keratinocytes and fibroblasts were isolated from uninjured adult skin. In addition, fibroblasts and adipose stem cells (ASC) from polydactyly and progenitor fibroblasts were used. Non-cross-linked HA Redensity 1® (RD1) solutions of varying concentrations were prepared and applied to various in vitro models. Cell viability, proliferation, migration, and collagen stimulation were assessed using standard assays. Additionally, cells were suspended in Redensity 1 and applied to an in vitro de-epidemalized dermis (DED) wound model to examine cell delivery and tissue reformation. Results: Preliminary data demonstrated the feasibility of using non-cross-linked HA RD1 gel as a cell carrier. RD1 gel enhanced cell viability, retention, migration, and collagen deposition. Histological analysis revealed improved cell adhesion and migration. Conclusions: This study provides valuable insight into the potential of non-cross-linked HA RD1 as a simple and effective delivery vehicle for cell therapies in early burn care. Successful translation of this approach could significantly improve clinical outcomes for burn patients.Keywords
All Related Versions
Funding Information
- Teoxane SA (32944/023)
This publication has 69 references indexed in Scilit:
- Stem Cell-Based Tissue Engineering for the Treatment of Burn Wounds: A Systematic Review of Preclinical StudiesStem Cell Reviews and Reports, 2022
- Engineering Pro‐Regenerative Hydrogels for Scarless Wound HealingAdvanced Healthcare Materials, 2018
- Experimental and Clinical Efficacy of Two Hyaluronic Acid-based Compounds of Different Cross-Linkage and Composition in the Rejuvenation of the SkinPharmaceutical Research, 2014
- Hyaluronan: A simple polysaccharide with diverse biological functionsActa Biomaterialia, 2014
- Hydrogels used for cell‐based drug deliveryJournal of Biomedical Materials Research Part A, 2008
- Isolation and characterization of mesenchymal cells from human fetal membranesJournal of Tissue Engineering and Regenerative Medicine, 2007
- In Vivo Stimulation of De Novo Collagen Production Caused by Cross-linked Hyaluronic Acid Dermal Filler Injections in Photodamaged Human SkinArchives of Dermatology, 2007
- Micromolding of photocrosslinkable hyaluronic acid for cell encapsulation and entrapmentJournal of Biomedical Materials Research Part A, 2006
- Stem Cell ResearchJAMA, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001